• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Feb 15, 1991; 88(4): 1291–1295.
PMCID: PMC51003

Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors.

Abstract

The protooncogene c-fos produces a phosphoprotein, Fos, which regulates gene transcription processes. In neuronal systems, Fos has been proposed to couple synaptic transmission to changes in gene expression by acting in the cell nucleus in concert with other proteins to form complexes in the promoter regions of target genes. We report here that the acute administration of a single dose of the indirect-acting dopaminergic agonist cocaine increases multiple Fos proteins in rat caudate nucleus. The increase is dose-dependent and is apparent immunocytochemically at 1 hr, maximal at 2 hr, and absent 48 hr after treatment. The increase seen immunocytochemically is composed of several molecular weight species as assessed by Western blotting of proteins from isolated striatal cell nuclei. Administration of the specific dopaminergic receptor antagonists sulpiride and SCH-23390 prior to cocaine support a significant role for D1 but not for D2 receptors in mediating this effect. These data indicate that D1 dopamine receptors are linked to a cellular immediate-early gene system(s) and suggest an action of cocaine at one or more levels of gene expression via modulation of transcriptional processes in activated cells.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Heikkila RE, Orlansky H, Cohen G. Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem Pharmacol. 1975 Apr 15;24(8):847–852. [PubMed]
  • Koe BK. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther. 1976 Dec;199(3):649–661. [PubMed]
  • Ross SB, Renyl AL. Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci. 1967 Jul 1;6(13):1407–1415. [PubMed]
  • HERTING G, AXELROD J, WHITBY LG. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J Pharmacol Exp Ther. 1961 Nov;134:146–153. [PubMed]
  • Goeders NE, Smith JE. Cortical dopaminergic involvement in cocaine reinforcement. Science. 1983 Aug 19;221(4612):773–775. [PubMed]
  • De Wit H, Wise RA. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol. 1977 Dec;31(4):195–203. [PubMed]
  • Risner ME, Jones BE. Intravenous self-administration of cocaine and norcocaine by dogs. Psychopharmacology (Berl) 1980;71(1):83–89. [PubMed]
  • Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol. 1978 Aug 1;180(3):545–580. [PubMed]
  • Palkovits M, Brownstein MJ, Zamir N. On the origin of dynorphin A and alpha-neo-endorphin in the substantia nigra. Neuropeptides. 1984 May;4(3):193–199. [PubMed]
  • Sivam SP. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther. 1989 Sep;250(3):818–824. [PubMed]
  • Li SJ, Sivam SP, McGinty JF, Jiang HK, Douglass J, Calavetta L, Hong JS. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther. 1988 Jul;246(1):403–408. [PubMed]
  • Hanson GR, Merchant KM, Letter AA, Bush L, Gibb JW. Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur J Pharmacol. 1987 Dec 1;144(2):245–246. [PubMed]
  • Hong JS, Yoshikawa K, Kanamatsu T, Sabol SL. Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Fed Proc. 1985 Jun;44(9):2535–2539. [PubMed]
  • Tang F, Costa E, Schwartz JP. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3841–3844. [PMC free article] [PubMed]
  • Clark D, White FJ. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse. 1987;1(4):347–388. [PubMed]
  • Stoof JC, Kebabian JW. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981 Nov 26;294(5839):366–368. [PubMed]
  • Cooper DM, Bier-Laning CM, Halford MK, Ahlijanian MK, Zahniser NR. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process. Mol Pharmacol. 1986 Feb;29(2):113–119. [PubMed]
  • Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science. 1987 May 8;236(4802):719–722. [PubMed]
  • Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989 Jul 28;245(4916):371–378. [PubMed]
  • Marriott SJ, Brady JN. Enhancer function in viral and cellular gene regulation. Biochim Biophys Acta. 1989 Dec 17;989(2):97–110. [PubMed]
  • Morgan JI, Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 1989 Nov;12(11):459–462. [PubMed]
  • Sheng M, Greenberg ME. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 1990 Apr;4(4):477–485. [PubMed]
  • Curran T, Miller AD, Zokas L, Verma IM. Viral and cellular fos proteins: a comparative analysis. Cell. 1984 Feb;36(2):259–268. [PubMed]
  • White JD, Gall CM. Differential regulation of neuropeptide and proto-oncogene mRNA content in the hippocampus following recurrent seizures. Brain Res. 1987 Dec;427(1):21–29. [PubMed]
  • Sonnenberg JL, Rauscher FJ, 3rd, Morgan JI, Curran T. Regulation of proenkephalin by Fos and Jun. Science. 1989 Dec 22;246(4937):1622–1625. [PubMed]
  • Draisci G, Iadarola MJ. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res. 1989 Jul;6(1):31–37. [PubMed]
  • Curran T, Gordon MB, Rubino KL, Sambucetti LC. Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene. 1987;2(1):79–84. [PubMed]
  • Giardina SL, Evans SW, Gandino L, Robey FA, Bonvini E, Longo DL, Varesio L. Generation of a murine monoclonal antibody that detects the fos oncogene product. Anal Biochem. 1987 Feb 15;161(1):109–116. [PubMed]
  • Quinn JP, Takimoto M, Iadarola M, Holbrook N, Levens D. Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers. J Virol. 1989 Apr;63(4):1737–1742. [PMC free article] [PubMed]
  • Tata JR. Isolation of nuclei from liver and other tissues. Methods Enzymol. 1974;31:253–262. [PubMed]
  • Russell WC, Newman C, Williamson DH. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature. 1975 Feb 6;253(5491):461–462. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Cohen DR, Curran T. fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Cell Biol. 1988 May;8(5):2063–2069. [PMC free article] [PubMed]
  • Zerial M, Toschi L, Ryseck RP, Schuermann M, Müller R, Bravo R. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 1989 Mar;8(3):805–813. [PMC free article] [PubMed]
  • Nishina H, Sato H, Suzuki T, Sato M, Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci U S A. 1990 May;87(9):3619–3623. [PMC free article] [PubMed]
  • Sonnenberg JL, Macgregor-Leon PF, Curran T, Morgan JI. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron. 1989 Sep;3(3):359–365. [PubMed]
  • Curran T, Franza BR., Jr Fos and Jun: the AP-1 connection. Cell. 1988 Nov 4;55(3):395–397. [PubMed]
  • Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274–5278. [PMC free article] [PubMed]
  • Berkowitz LA, Riabowol KT, Gilman MZ. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol Cell Biol. 1989 Oct;9(10):4272–4281. [PMC free article] [PubMed]
  • Hyman SE, Comb M, Lin YS, Pearlberg J, Green MR, Goodman HM. A common trans-acting factor is involved in transcriptional regulation of neurotransmitter genes by cyclic AMP. Mol Cell Biol. 1988 Oct;8(10):4225–4233. [PMC free article] [PubMed]
  • Sassone-Corsi P, Visvader J, Ferland L, Mellon PL, Verma IM. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 1988 Dec;2(12A):1529–1538. [PubMed]
  • Bravo R, Neuberg M, Burckhardt J, Almendral J, Wallich R, Müller R. Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages. Cell. 1987 Jan 30;48(2):251–260. [PubMed]
  • Kousvelari E, Louis JM, Huang LH, Curran T. Regulation of proto-oncogenes in rat parotid acinar cells in vitro after stimulation of beta-adrenergic receptors. Exp Cell Res. 1988 Nov;179(1):194–203. [PubMed]
  • Mocchetti I, De Bernardi MA, Szekely AM, Alho H, Brooker G, Costa E. Regulation of nerve growth factor biosynthesis by beta-adrenergic receptor activation in astrocytoma cells: a potential role of c-Fos protein. Proc Natl Acad Sci U S A. 1989 May;86(10):3891–3895. [PMC free article] [PubMed]
  • Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, Machida CA, Neve KA, Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature. 1988 Dec 22;336(6201):783–787. [PubMed]
  • Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 1989 Dec 21;342(6252):923–926. [PubMed]
  • Monsma FJ, Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature. 1989 Dec 21;342(6252):926–929. [PubMed]
  • Chio CL, Hess GF, Graham RS, Huff RM. A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus. Nature. 1990 Jan 18;343(6255):266–269. [PubMed]
  • Robertson HA, Peterson MR, Murphy K, Robertson GS. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res. 1989 Dec 4;503(2):346–349. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...